Journal of Medicinal Chemistry p. 2130 - 2137 (1995)
Update date:2022-08-03
Topics:
Sawyer, David A.
Beams, Richard M.
Blackwell, Geoffrey, J.
Brockwell, Michael A.
Cheesman, Neil J.
et al.
The synthesis and structure-activity relationship (SAR) analysis of a novel series of trialkoxyaryl derivatives as specific and competetive inhibitors of platelet activating factor (PAF), are described.Molecular modeling comparisons of PAF with the known antagonists Ginkgolide B and L-652731 led to the selection of N-<2-<(3,4,5-trimethoxybenzoyl)oxy>ethyl>-N,N,N-trimethylammonium iodide (1) from the Wellcome registry of compounds and to the synthesis of the lead compound N-<2-<<4-(hexyloxy)-3,5-dimethoxybenzoyl>oxy>ethyl>-N,N,N-trimethylammonium iodide (3, pKb 5.43).Furth er SAR considerations directed the design to 2-(hexyloxy)-1,3-dimethoxy-5-<4-(4-methylthiazol-5-yl)butyl>benzene (38) (pKb 7.14), a novel, specific, and competitive inhibitor of the PAF receptor in rabbit-washed platelets.
View MoreYangzhou Siyu Chemical Co.,Ltd.
Contact:+86-514-87325867 13358126196
Address:Room 620 Exposition Pavilion,No. 98 Huaihai Road,Guangling District,Yangzhou City, Jiangsu Province
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Hunan Haili Chemical Industry Co.,Ltd.
Contact:+86-731-85521860
Address:No.251, 2nd Section, Furong Road, Changsha,Hunan,China
Alpha(shijiazhuang) Chemical Co., Ltd
Contact:+86-311-85652680
Address:Shijiazhuang City ,Hebei Province China
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Doi:10.1016/j.cclet.2019.03.038
(2019)Doi:10.1021/ja01014a042
(1968)Doi:10.1016/j.ab.2011.07.024
(2011)Doi:10.1021/jo020302e
(2002)Doi:10.3390/molecules25071578
(2020)Doi:10.1016/j.tet.2016.08.070
(2016)